Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

ClinicalTrials.gov ID: NCT01154140

Public ClinicalTrials.gov record NCT01154140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Open-label Study Of The Efficacy And Safety Of Crizotinib Versus Pemetrexed/Cisplatin Or Pemetrexed/Carboplatin In Previously Untreated Patients With Non-squamous Carcinoma Of The Lung Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase (Alk) Gene Locus.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the anti-cancer effects of crizotinib when compared with standard chemotherapy in patients with ALK positive lung cancer.

Study identification

NCT ID
NCT01154140
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
343 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2011 (Actual)
Primary completion
Nov 30, 2013 (Actual)
Completion
Nov 30, 2016 (Actual)
Last update posted
Nov 6, 2017

2011 – 2016

United States locations

U.S. sites
84
U.S. states
21
U.S. cities
56
Facility City State ZIP Site status
Tower Cancer Research Foundation Beverly Hills California 90211-1850 —
Tower Hematology Oncology Medical Group Beverly Hills California 90211-1850 —
CCTAP Fontana California 92335 —
Loma Linda University Cancer Center Loma Linda California 92350 —
Loma Linda University Cancer Center (LLUCC)-Schuman Pavilion Loma Linda California 92354 —
Loma Linda University Medical Center Loma Linda California 92354 —
CCTAP Los Angeles California 90027 —
Kaiser Permanente Southern California San Diego California 92108 —
CCTAP San Diego California 92120 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Research Pharmacy, Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Lynn Cancer Institute Center for Hematology Oncology Boca Raton Florida 33486 —
Florida Hospital Orlando Florida 32803 —
Cancer Institute of Florida Orlando Florida 32804 —
Investigational Drug Services Orlando Florida 32804 —
Georgia Cancer Specialists Athens Georgia 30606 —
Georgia Cancer Specialists Atlanta Georgia 30341 —
Georgia Cancer Specialists Decatur Georgia 30033 —
Georgia Cancer Specialists Macon Georgia 31217 —
Georgia Cancer Specialists Marietta Georgia 30060 —
Georgia Cancer Specialists Sandy Springs Georgia 30342 —
University of Chicago Chicago Illinois 60637 —
Al Fisher, Pharm D. Harvey Illinois 60426 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Monroe Medical Associates Harvey Illinois 60426 —
Monroe Medical Associates Tinley Park Illinois 60477 —
Indiana University Hospital Indianapolis Indiana 46202 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
Lois and Eskenazi Hospital Indianapolis Indiana 46202 —
Monroe Medical Association Munster Indiana 46321 —
The Community Hospital Munster Indiana 46321 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Maine Center for Cancer Medicine Biddeford Maine 04005 —
Maine Center for Cancer Medicine Brunswick Maine 04011 —
Maine Center for Cancer Medicine Sanford Maine 04073 —
Maine Center for Cancer Medicine Scarborough Maine 04074 —
Kresge Eye Institute Bingham Farms Michigan 48025 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Kresge Eye Institute Detroit Michigan 48201 —
Karmanos Cancer Institute at Farmington Hills Farmington Hills Michigan 48334 —
Siteman Cancer Center City of Saint Peters Missouri 63376 —
Siteman Cancer Center - West County Creve Coeur Missouri 63141 —
Barnes-Jewish Hospital St Louis Missouri 63110-1094 —
Washington University Center for Advanced Medicine Infusion Center Pharmacy St Louis Missouri 63110 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756-0001 —
Hematology-Oncology Associates of Northern New Jersey Morristown New Jersey 07962 —
University of New Mexico Cancer Center Albuquerque New Mexico 87106 —
UNM Eye Clinic Albuquerque New Mexico 87106 —
Memorial Medical Center Las Cruces New Mexico 88011 —
NSLIJ Health System/Monter Cancer Center Lake Success New York 11042 —
North Shore University Hospital Manhasset New York 11030 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
SUNY Upstate Medical University Syracuse New York 13210 —
OHSU Knight Cancer Institute Beaverton Oregon 97006 —
OHSU Knight Cancer Institute Gresham Oregon 97030 —
OHSU Knight Cancer Institute Portland Oregon 97210 —
OHSU Knight Cancer Institute Portland Oregon 97216 —
Oregon Health and Science University Portland Oregon 97239 —
OHSU Knight Cancer Institute Tualatin Oregon 97062 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Vincent Armenio East Providence Rhode Island 02914 —
Pharma Resource East Providence Rhode Island 02915 —
Tennessee Oncology, PLLC Dickson Tennessee 37055 —
Tennessee Oncology, PLLC Franklin Tennessee 37067 —
Tennessee Oncology, PLLC Gallatin Tennessee 37066 —
Tennessee Oncology, PLLC Hermitage Tennessee 37076 —
Tennessee Oncology, PLLC Lebanon Tennessee 37087 —
Tennessee Oncology, PLLC Murfreesboro Tennessee 37130 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Nashville Tennessee 37205 —
Tennessee Oncology, PLLC Nashville Tennessee 37207 —
Tennessee Oncology, PLLC Nashville Tennessee 37211 —
Henry-Joyce Cancer Clinic Nashville Tennessee 37232-5536 —
Vanderbilt Oncology Pharmacy Nashville Tennessee 37232-7610 —
Tennessee Oncology, PLLC Smyrna Tennessee 37167 —
UT Southwestern Medical Center - Simmons Cancer Center Pharmacy Dallas Texas 75390-9015 —
UT Southwestern Medical Center Dallas Texas 75390 —
UT Southwestern University Hospital - William P. Clements, Jr. Dallas Texas 75390 —
UT Southwestern University Hospital - Zale Lipshy Dallas Texas 75390 —
University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
University of Washington Medical Center Seattle Washington 98195 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792-5666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01154140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01154140 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →